Project Grant HT94252411110
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$3.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84112, USA
Similar Awards
The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The...
This federal Project Grant award of $1,539,865.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Utah to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The project, set to run from August 1, 2024 to July 31, 2028, will leverage the university's expertise in biomedical research and healthcare services to advance knowledge in this critical area. The...
This $746,410 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the University of Utah supports research to investigate "Tissue Softening as a Biomarker of Traumatic Brain Injury." The award, effective from August 15, 2024 to August 14, 2027, will enable the university to conduct cutting-edge biomedical research aimed at developing improved diagnostic and treatment approaches for traumatic brain injury, a critical health...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
The University of Utah received a $1,499,903 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a "HIGH-PERFORMANCE POWERED ANKLE/FOOT PROSTHESIS FOR BELOW-KNEE AMPUTEES". The award has a performance period from August 1, 2024 to July 31, 2028. As part of this grant, the University of Utah is collaborating with a subrecipient, Otto Bock Healthcare LP, a prosthetics manufacturer, to design and produce...
This federal Project Grant award of $400,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, with a performance period from October 1, 2024 to September 30, 2026. The award supports research by the University of Maryland, Baltimore to develop "drug conjugates of modified LGR4/5/6 ligands for cancer treatment." The university, as the prime awardee, has extensive expertise in biomedical research, clinical trials, and...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
This federal Project Grant award of $462,000.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, will support the University of Utah's research project titled "ADVANCING RISK PREDICTION AND PREVENTION TO MITIGATE THE BURDEN OF CARDIOVASCULAR DISEASE IN MEN WITH PROSTATE CANCER." The award, with a performance period from Sep 15, 2024 to Sep 14, 2026, will fund advanced biomedical research initiatives...
The federal Project Grant award of $5,099,737.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a myeloid-targeted novel therapeutic for glomerular diseases. The award, with a performance period from July 1, 2025 to June 30, 2029, was granted to 149 Bio LLC, a for-profit organization located in Miami, Florida. The funded research aims to transform healthcare for military service members, veterans, and the broader public...
This Project Grant award of $1,539,469.00 from the Defense Health Agency was provided to the University of Utah under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Molecular Crosstalk Between Estrogens and Progestogens in Endometrial Cancer." The award will fund this biomedical research project from September 1, 2023 to August 31, 2026. The University of Utah has an extensive track record of collaborating with government agencies on...